Skip to main content
. 2024 Sep 15;16(9):4967–4978. doi: 10.62347/ARYA8831

Table 3.

Comparison of renal function indicators (x̅±sd)

Group UAER (µg/min) 24 h Urinary Protein (mg/24 h) UmALB (mg/L)



Before Treatment After Treatment Before Treatment After Treatment Before Treatment After Treatment
Early SGLT2-i group (n = 88) 155.36±16.38 89.35±9.24* 263.57±28.41 170.36±17.52* 66.32±11.42 34.75±10.16*
Late SGLT2-i group (n = 90) 155.81±16.20 97.42±10.03* 265.14±28.03 188.25±20.46* 66.58±11.72 48.57±10.29*
t 0.184 5.580 0.371 6.260 0.147 9.023
P 0.854 < 0.001 0.711 < 0.001 0.883 < 0.001
*

P < 0.05 compared to pre-treatment within the same group;

UAER, urinary albumin excretion rate; UmALB, uric micro-albuminiuria; SGLT2-i, sodium-glucose cotransporter 2 inhibitor.